Last 12 months
Inside the activity.
1 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2022 Filed Jan 28, 2022 21:16 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,630 | $37.13 | $97,651.90 |
DisclosureSEC source: 0001179110-22-000648 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 436,416 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.52, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7) and (8). F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:14 UTC |
Livingston Mark S.Chief Financial Officer
|
Tax withholdingCommon Stock | 259 | $38.16 | $9,883.44 |
DisclosureSEC source: 0001179110-22-000647 · edgar.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,810 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person on May 4, 2020. Read SEC document |
| January 25, 2022 Filed Mar 2, 2022 23:20 UTC Amendment |
Anevski PeterChief Executive Officer
|
GiftCommon Stock | 128,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001966 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 190,735 F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 25, 2022 Filed Mar 2, 2022 23:20 UTC Amendment |
Anevski PeterChief Executive Officer
|
GiftCommon Stock | 128,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001966 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,927 F1 · balance_after: Includes 445 common shares acquired under the Issuer's employee stock purchase plan. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,085 | $40.28 | $83,983.80 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 439,046 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.105 to $40.50, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,731 | $39.55 | $147,561.05 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footote Disclosed balance after: 441,131 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.10 to $40.09, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,514 | $38.32 | $96,336.48 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 444,862 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.10 to $38.73, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 500 | $40.37 | $20,185.00 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 447,376 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.26 to $40.45, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,985 | $39.56 | $157,646.60 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 447,876 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.22 to $40.16, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 22:00 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,845 | $38.68 | $148,724.60 |
DisclosureSEC source: 0001179110-22-000557 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 451,861 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.21 to $39.17, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8) and (9). F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 100 | $45.75 | $4,575.00 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 455,706 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,714 | $44.87 | $166,647.18 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 455,806 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F8 · price: ) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.56 to $45.39, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,516 | $44.05 | $198,929.80 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 459,520 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.55 to $44.54, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 633 | $47.65 | $30,162.45 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 464,036 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.49 to $47.745, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,896 | $46.94 | $229,818.24 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See attached Disclosed balance after: 464,669 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.46 to $47.45, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 22:42 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,801 | $45.53 | $127,529.53 |
DisclosureSEC source: 0001179110-22-000511 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 469,565 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.26 to $46.05, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:52 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,730 | $46.22 | $311,060.60 |
DisclosureSEC source: 0001179110-22-000342 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 472,366 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.67 to $46.64, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:52 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,600 | $45.18 | $72,288.00 |
DisclosureSEC source: 0001179110-22-000342 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 479,096 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.66 to $45.61, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:52 UTC |
Payson NormanDirector
|
SaleCommon Stock | 300 | $48.06 | $14,418.00 |
DisclosureSEC source: 0001179110-22-000342 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 480,696 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.18, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:52 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,600 | $47.54 | $218,684.00 |
DisclosureSEC source: 0001179110-22-000342 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 480,996 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.95 to $47.85, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:52 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,430 | $46.15 | $158,294.50 |
DisclosureSEC source: 0001179110-22-000342 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 485,596 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.945 to $46.87, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), and (8). F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 704 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,183,680 Underlying: Common Stock · 704 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
SaleCommon Stock | 704 | $51.27 | $36,094.08 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.08 to $51.76, inclusive. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 704 | $0.91 | $640.64 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:19 UTC |
Anevski PeterChief Executive Officer
|
SaleCommon Stock | 400 | $51.06 | $20,424.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 62,600 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F4 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.91 to $51.225, inclusive. F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
SaleCommon Stock | 50,000 | $51.17 | $2,558,500.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.93 to $51, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC |
Anevski PeterChief Executive Officer
|
SaleCommon Stock | 21,000 | $51.17 | $1,074,570.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 63,000 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 26, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.93 to $51.62, inclusive. F4 · price: Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC |
Anevski PeterChief Executive Officer
|
GiftCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 84,000 F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:19 UTC |
Anevski PeterChief Executive Officer
|
GiftCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000280 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,617 Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 21:45 UTC |
Schlanger David JDirector · Executive Chairman
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 333,000 | $0.00 Strike: $50.35 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,000 Underlying: Common Stock · 333,000 shares Expires 2031-12-31 F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 21:45 UTC |
Schlanger David JDirector · Executive Chairman
|
GrantCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F4 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 23:23 UTC |
Anevski PeterChief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $50.35 | $0.00 |
DisclosureSEC source: 0001179110-22-000020 · edgar.xml · derivative · entry 2 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-12-31 F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 23:23 UTC |
Anevski PeterChief Executive Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000020 · edgar.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,617 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 23:13 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,210 | $52.23 | $167,658.30 |
DisclosureSEC source: 0001179110-22-000018 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 489,026 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.05 to $52.58, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 23:13 UTC |
Payson NormanDirector
|
SaleCommon Stock | 5,120 | $51.57 | $264,038.40 |
DisclosureSEC source: 0001179110-22-000018 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 492,236 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.035 to $52.025, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 23:13 UTC |
Payson NormanDirector
|
SaleCommon Stock | 5,410 | $52.09 | $281,806.90 |
DisclosureSEC source: 0001179110-22-000018 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 497,356 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.85 to $52.38, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 23:13 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,920 | $51.57 | $150,584.40 |
DisclosureSEC source: 0001179110-22-000018 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 502,766 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.85 to $51.84, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5). F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 73,095 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,234,384 Underlying: Common Stock · 73,095 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC |
Schlanger David JDirector · Executive Chairman
|
SaleCommon Stock | 73,095 | $52.18 | $3,814,097.10 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.11 to $52.39, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 73,095 | $0.91 | $66,516.45 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 66,005 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,307,479 Underlying: Common Stock · 66,005 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
SaleCommon Stock | 66,005 | $52.40 | $3,458,662.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.39 to $52.61, inclusive. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 66,005 | $0.81 | $53,464.05 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,373,484 Underlying: Common Stock · 10,900 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
SaleCommon Stock | 10,900 | $52.80 | $575,520.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.68 to $53.15, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC |
Schlanger David JDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,900 | $0.91 | $9,919.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:36 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,630 | $51.65 | $342,439.50 |
DisclosureSEC source: 0001179110-21-011240 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 505,686 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6) and (7). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.49 to $51.86, inclusive. F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:36 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,700 | $51.07 | $86,819.00 |
DisclosureSEC source: 0001179110-21-011240 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 512,316 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6) and (7). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.49 to $51.48, inclusive F4 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.